US equities
|
NVDA
$221.30
▼-3.16%
MU
$914.13
▼-4.10%
AAPL
$342.96
▲+0.50%
AMD
$570.82
▼-5.73%
META
$737.54
▼-3.27%
MSFT
$533.69
▼-1.80%
TSLA
$367.16
▼-2.15%
SPCX
$152.16
▼-2.80%
NVDA
$221.30
▼-3.16%
MU
$914.13
▼-4.10%
AAPL
$342.96
▲+0.50%
AMD
$570.82
▼-5.73%
META
$737.54
▼-3.27%
MSFT
$533.69
▼-1.80%
TSLA
$367.16
▼-2.15%
SPCX
$152.16
▼-2.80%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
DENTSPLY SIRONA Inc. - Common Stock
(NQ:
XRAY
)
8.440
-0.065 (-0.76%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DENTSPLY SIRONA Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q2 Earnings?
October 09, 2026
Dentsply Sirona has gotten torched over the last six months - since April 2026, its stock price has dropped 27.3% to $8.62 per share. This may have investors...
Via
StockStory
3 Stocks Under $10 Walking a Fine Line
September 28, 2026
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many ...
Via
StockStory
Q2 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
September 24, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how dental equipment & tec...
Via
StockStory
1 Value Stock with Impressive Fundamentals and 2 Facing Headwinds
September 23, 2026
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the...
Via
StockStory
Dentsply Sirona (NASDAQ:XRAY) Shares Rally 5% After Mixed Q1 Results Beat Revenue Estimates
↗
May 05, 2026
Via
Chartmill
Robbins Geller Rudman & Dowd LLP Announces Pending Class Action Lawsuit in the Dentsply Securities Litigation
September 11, 2026
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
3 Russell 2000 Stocks We Steer Clear Of
September 11, 2026
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...
Via
StockStory
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
September 03, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be...
Via
StockStory
1 Stock Under $50 to Research Further and 2 Facing Headwinds
August 24, 2026
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...
Via
StockStory
3 Unprofitable Stocks with Open Questions
August 20, 2026
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Via
StockStory
Dentsply Sirona (XRAY) Q2 2026 Earnings Call Transcript
↗
August 14, 2026
Revenue declined 4.1% as restructuring efforts begin to take hold.
Via
The Motley Fool
Topics
Earnings
World Trade
The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q2 Earnings Call
August 13, 2026
Dentsply Sirona’s second quarter results were met with a negative market reaction, as shares declined following revenue and non-GAAP earnings that exceeded W...
Via
StockStory
Topics
Earnings
World Trade
Why Dentsply Sirona (XRAY) Stock Is Trading Lower Today
August 07, 2026
What Happened? Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) fell 6.8% in the afternoon session after the company reported second-quarter 2...
Via
StockStory
XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds
August 07, 2026
Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q2 CY2026, but sales fell by 4.1% year on year to $898 millio...
Via
StockStory
Topics
World Trade
DENTSPLY SIRONA Q2 Earnings Call Highlights
↗
August 07, 2026
DENTSPLY SIRONA (NASDAQ:XRAY) reported second-quarter 2026 revenue of $898 million, down 4.1% on a reported basis and 6.3% on a constant-currency basis, as the dental products company continued its...
Via
MarketBeat
Topics
Earnings
World Trade
Dentsply Sirona (NASDAQ:XRAY) Beats Q2 CY2026 Sales Expectations
August 06, 2026
Dental products company Dentsply Sirona (NASDAQ:XRAY) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 4.1% year on ye...
Via
StockStory
Earnings To Watch: Dentsply Sirona (XRAY) Reports Q2 Results Tomorrow
August 04, 2026
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting results this Thursday after market hours. Here’s what investors should know. Dentsply...
Via
StockStory
3 Reasons to Sell XRAY and 1 Stock to Buy Instead
July 24, 2026
Dentsply Sirona has been treading water for the past six months, recording a small loss of 0.5% while holding steady at $12.66. The stock also fell short of ...
Via
StockStory
Dental Equipment & Technology Stocks Q1 In Review: Dentsply Sirona (NASDAQ:XRAY) Vs Peers
June 23, 2026
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Dentsply Sirona (NASDAQ:XRAY) and i...
Via
StockStory
3 Small-Cap Stocks We Think Twice About
June 16, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via
StockStory
3 Unprofitable Stocks That Fall Short
June 09, 2026
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...
Via
StockStory
1 Cash-Producing Stock with Exciting Potential and 2 We Avoid
June 05, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...
Via
StockStory
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know
May 13, 2026
What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi...
Via
StockStory
Topics
Economy
The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q1 Earnings Call
May 12, 2026
Dentsply Sirona’s first quarter results reflected a company in the midst of operational transformation, with revenue holding steady year over year but outper...
Via
StockStory
Topics
Earnings
World Trade
Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript
↗
May 06, 2026
Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
World Trade
XRAY Q1 Deep Dive: Revenue Flat as Dentsply Sirona Advances Restructuring and Product Initiatives
May 06, 2026
Dental products company Dentsply Sirona (NASDAQ:XRAY) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year...
Via
StockStory
Dentsply Sirona (NASDAQ:XRAY) Beats Q1 CY2026 Sales Expectations
May 05, 2026
Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q1 CY2026, but sales were flat year on year at $880 million. ...
Via
StockStory
Dentsply Sirona (XRAY) Reports Q1: Everything You Need To Know Ahead Of Earnings
May 03, 2026
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting results this Tuesday after the bell. Here’s what investors should know. Dentsply Siro...
Via
StockStory
Dental Equipment & Technology Stocks Q4 Recap: Benchmarking Dentsply Sirona (NASDAQ:XRAY)
April 26, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how dental equipment ...
Via
StockStory
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
April 17, 2026
What Happened? A number of stocks jumped in the afternoon session as the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy ...
Via
StockStory
Topics
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
